Enhancing Self-Esteem in Patients With Multiple Sclerosis: A Randomised Controlled Trial of the Lexical Association Technique
NCT07064291 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2025-07-14
Summary
The goal of this clinical trial is to learn whether the Lexical Association Technique (LAT) can improve well-being in people recently diagnosed with multiple sclerosis (MS), either relapsing-remitting (RRMS) or secondary progressive (SPMS).
The main questions it aims to answer are:
* Does the LAT increase well-being more than a placebo technique ?
* Does this technique help reduce psychological distress and improve quality of life ?
Participants will:
* Be randomly assigned to either the LAT group or the active control group
* Complete short visualization exercises at home using a personal computer
* Fill out questionnaires about self-esteem, stress, anxiety, depression, quality of life, and adjustment to illness
* Take part in the study over several weeks, with assessments before, after, and 14 days after the intervention
Researchers will compare results between the two groups (LAT group vs. Control group) to test the immediate and lasting effects of the LAT.
Conditions
- Multiple Sclerosis
- Quality of Life (QOL)
Interventions
- OTHER
-
The Lexical Association Technique (LAT)
The Lexical Association Technique (LAT) was developed by Niveau, New, and Beaudoin in 2021 (Niveau et al., 2022). It is grounded in principles of memory functioning described in the cognitive psychology literature, particularly the theoretical framework of the Self-Memory System proposed by Conway (2000, 2005). The technique aims to enhance self-esteem by strengthening associative links between the self and positively valenced concepts stored in memory. To achieve this, it relies on the repeated mental visualization of positive autobiographical episodes paired with positive self-referential linguistic statements. The effectiveness of this technique in increasing self-esteem has been demonstrated and replicated across three studies, conducted with distinct samples: two involving healthy participants and one involving a clinical sample of individuals with a chronic illness (Niveau et al., 2022, 2023).
- OTHER
-
Placebo of the Lexical Association Technique
The active control condition is based on the same procedural structure as the Lexical Association Technique (LAT), but without the core therapeutic component - the self-referential content. Participants in the control group are exposed to a series of positive statements, similar in form and valence to those used in the LAT, but referring to others (e.g., generic social roles or entities such as teachers, pharmacists, or animals) rather than the self. Like in the LAT condition, participants are asked to generate mental imagery based on each statement, visualizing a corresponding positive episodic event. This ensures that the control task involves the same cognitive mechanisms (episodic memory retrieval, positive visualization, and sustained attention), while excluding the specific associative link to the self that constitutes the active ingredient of the intervention. This control condition was designed to match the LAT in terms of structure, cognitive demand, and duration, and has be
Sponsors & Collaborators
-
Laboratoire interuniversitaire de psychologie : personnalité, cognition et changement social - LIP-PC2S
collaborator UNKNOWN -
Laboratoire de Psychologie et NeuroCognition
collaborator OTHER -
University Hospital, Grenoble
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-30
Countries
- France
Study Locations
More Related Trials
-
Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis
NCT07028879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Validation of the French Adaptation of the MSWDQ-23 Questionnaire
NCT04860791 ·Status: COMPLETED
-
The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01707992 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple Sclerosis
NCT05033782 ·Status: COMPLETED
-
Study of Empathy in MS
NCT05332951 ·Status: COMPLETED
-
Validation of a Self-questionnaire in French on the Use of the Upper Limbs in Patients With Multiple Sclerosis
NCT03655093 ·Status: COMPLETED
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Telerehabilitation for Multiple Sclerosis
NCT06871072 ·Status: COMPLETED ·Phase: NA
-
The MS-LINK™ Outcomes Study
NCT04735406 ·Status: COMPLETED
-
Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility Trial
NCT04975685 ·Status: RECRUITING ·Phase: NA
-
Social and Moral Cognition in Multiple Sclerosis
NCT06318923 ·Status: RECRUITING ·Phase: NA
-
Remote Evaluation in Patients With Multiple Sclerosis
NCT06308042 ·Status: NOT_YET_RECRUITING
-
Cognition Evolution and MRI Markers in PPMS Patients on 2 Years
NCT03455582 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis
NCT05320237 ·Status: COMPLETED ·Phase: NA
-
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
NCT04233970 ·Status: COMPLETED ·Phase: NA
-
Effect of the Vojta Therapy in Patients Multiple Sclerosis
NCT05558683 ·Status: UNKNOWN ·Phase: NA
-
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
NCT05758831 ·Status: RECRUITING ·Phase: PHASE3
-
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
NCT07222618 ·Status: RECRUITING
-
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
NCT01392872 ·Status: COMPLETED ·Phase: NA
-
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography
NCT04705610 ·Status: COMPLETED ·Phase: NA
-
Emotions in Multiple Sclerosis
NCT04804787 ·Status: COMPLETED ·Phase: NA
-
Pilot and Feasibility Trial of a Telehealth Dietary Intervention for MS
NCT03372187 ·Status: COMPLETED ·Phase: NA
-
Self Help for Fatigue in Multiple Sclerosis
NCT01532037 ·Status: COMPLETED ·Phase: NA
-
Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis
NCT05519553 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Efficacy of Pulse Therapy in Acute Relapse in Multiple Sclerosis Patients:
NCT06280131 ·Status: NOT_YET_RECRUITING